Voyager Therapeutics Announces License Option Agreement With Pfizer For Next-Generation TRACER AAV Capsids To Enable Neurologic And Cardiovascular Gene Therapy Programs Read more
Acer Therapeutics and Relief Therapeutics Announce FDA Acceptance for Filing of New Drug Application for ACER-001 to Treat Urea Cycle Disorders Read more
GSK welcomes WHO recommendation for broad roll-out of its RTS,S/AS01e (RTS,S) malaria vaccine Read more
EQRx and Absci Announce Partnership to Discover and Develop Next-Generation Protein-Based Drugs Read more
Moderna Announces European Medicines Agency Authorizes Third Dose of COVID-19 Vaccine for Immunocompromised Individuals Aged 12 Years and Older Read more